S.Rajapakse,C.Rodrigo,S.Maduranga,AC.Rajapakse.Corticosteroids in the treatment of dengue shock syndrome..„Infect Drug Resist”.7,s.137-43,2014. DOI: 10.2147/IDR.S55380. PMID: 24899817.
A.Sridharan,Q.Chen,KF.Tang,EE.Ooii inni.Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice..„J Virol”.87(21),s.11648-58,Nov2013. DOI: 10.1128/JVI.01156-13. PMID: 23966397.
M.Saito,K.Oishi,S.Inoue,EM.Dimaanoi inni.Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections..„Clin Exp Immunol”.138(2),s.299-303,Nov2004. DOI: 10.1111/j.1365-2249.2004.02626.x. PMID: 15498040.
S.Wang,R.He,J.Patarapotikul,BL.Innisi inni.Antibody-enhanced binding of dengue-2 virus to human platelets..„Virology”.213(1),s.254-7,Oct1995. DOI: 10.1006/viro.1995.1567. PMID: 7483271.
DS.Sun,CC.King,HS.Huang,YL.Shihi inni.Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice..„J Thromb Haemost”.5(11),s.2291-9,Nov2007. DOI: 10.1111/j.1538-7836.2007.02754.x. PMID: 17958746.
CPSimmons,Farrar, JJ; Nguyen, vV; Wills, B.Dengue.„The New England Journal of Medicine”.366(15),s.1423–32,2012-04-12. DOI: 10.1056/NEJMra1110265. PMID: 22494122.
VWiwanitkit.Dengue fever: diagnosis and treatment.„Expert review of anti-infective therapy”.8(7),s.841–5,2010 Jul. DOI: 10.1586/eri.10.53. PMID: 20586568.
Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, Lang J.From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine.„Vaccine”.29(42),s.7229–41,92011. DOI: 10.1016/j.vaccine.2011.06.094. PMID: 21745521.
S.Rajapakse,C.Rodrigo,S.Maduranga,AC.Rajapakse.Corticosteroids in the treatment of dengue shock syndrome..„Infect Drug Resist”.7,s.137-43,2014. DOI: 10.2147/IDR.S55380. PMID: 24899817.
A.Sridharan,Q.Chen,KF.Tang,EE.Ooii inni.Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice..„J Virol”.87(21),s.11648-58,Nov2013. DOI: 10.1128/JVI.01156-13. PMID: 23966397.
M.Saito,K.Oishi,S.Inoue,EM.Dimaanoi inni.Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections..„Clin Exp Immunol”.138(2),s.299-303,Nov2004. DOI: 10.1111/j.1365-2249.2004.02626.x. PMID: 15498040.
S.Wang,R.He,J.Patarapotikul,BL.Innisi inni.Antibody-enhanced binding of dengue-2 virus to human platelets..„Virology”.213(1),s.254-7,Oct1995. DOI: 10.1006/viro.1995.1567. PMID: 7483271.
DS.Sun,CC.King,HS.Huang,YL.Shihi inni.Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice..„J Thromb Haemost”.5(11),s.2291-9,Nov2007. DOI: 10.1111/j.1538-7836.2007.02754.x. PMID: 17958746.
CPSimmons,Farrar, JJ; Nguyen, vV; Wills, B.Dengue.„The New England Journal of Medicine”.366(15),s.1423–32,2012-04-12. DOI: 10.1056/NEJMra1110265. PMID: 22494122.
VWiwanitkit.Dengue fever: diagnosis and treatment.„Expert review of anti-infective therapy”.8(7),s.841–5,2010 Jul. DOI: 10.1586/eri.10.53. PMID: 20586568.
Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, Lang J.From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine.„Vaccine”.29(42),s.7229–41,92011. DOI: 10.1016/j.vaccine.2011.06.094. PMID: 21745521.